Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 88,800 shares at $6.95 ($605K) on 2020-12-11, disclosed to the SEC on 2020-12-15.
Open-market sale of $605k PRTK by Executive Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.95 | 18,337 | $127K | 21.1% |
| 2 | $6.95 | 18,337 | $127K | 21.1% |
| 3 | $6.71 | 26,063 | $175K | 28.9% |
| 4 | $6.71 | 26,063 | $175K | 28.9% |
| Total | $6.81 avg | 88,800 | $605K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |